One in Five Women Will Develop a Pelvic Mass
Aspira Labs® is focused on women’s health and caring for our patients in all stages of their lives. We believe that all patients should have access to the best testing options available. Learn more about our tests, find educational information, and resources for you in the links below.
There are approximately 22,500 cases of ovarian cancer (all subtypes) annually in the United States, which accounts for about 1.3% of all new cancer cases.1
A pelvic mass, also known as an ovarian or adnexal mass, is a tissue mass in the adnexa of the uterus, which refers to the space occupied by the uterus, ovaries and fallopian tubes. Ovarian masses can be a risk factor for ovarian cancer, however, most masses are often not cancer and go away on their own without treatment within a few menstrual cycles.
Hereditary Cancer Genetic Risk
Women and men with a hereditary breast or ovarian cancer mutation have a higher chance of developing cancer, especially at a younger age. These mutations may be identified through genetic testing even before cancer develops. Identifying if you have a genetic risk can be important for cancer prevention, detection, and treatment.
Carrier Screening Genetic Testing
Carrier Screening is designed to identify potential reproductive risks for a current or future pregnancy. Every person is a carrier for a number of genetic changes that could cause disease in their child. Typically, carriers of a genetic condition are healthy and are not aware of their risk. If their partner is also a carrier for the same condition, they are at an increased risk of having a child affected with a severe genetic condition. Most people are not aware of their carrier status because they do not have symptoms or a family history of the disease.
- National Cancer Institute. (2019). SEER Cancer Stat Facts: Ovarian Cancer. www.seer.cancer.gov/statfacts/html/ovary.html